NCT07378319
Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Feb 1, 2026 to Sep 1, 2026 Show 6 more changesShow less
- Eligibility criteria expanded, about 13 words
- Trial completed
- Final enrollment: 10 participants (planned 15)
- Study completion date changed from estimate of Jun 28, 2026 to Oct 28, 2026
- Secondary endpoints: details revised at 2 of 3 entries
- Site details revised
- Minor Study completion date: Feb 28, 2026 to Jun 28, 2026
- Study title revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (3)
Arms and interventions
Participants in this single experimental arm will receive three sessions of ultrasound-guided dextrose injections (e.g., 5% or 15% Dextrose) targeting symptomatic myofascial and interfascial planes of the ipsilateral chest wall and axilla, such as the pectoralis major-minor interface or axillary fascia. Injections are administered at 4-week intervals (at Baseline, Week 4, and Week 8). Throughout the 6-month study period, all participants continue their standardized rehabilitation program, which includes range-of-motion exercises, stretching of the chest wall and axillary musculature, and progressive strengthening.
Procedures: ultrasound guided dextrose prolotherapy
Sites
1 site in 1 country
- Taichung Veterans Genetal HospitalTaichung, Taiwan, Taiwan